Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,544
Closed -$677K 61
2024
Q1
$677K Buy
3,544
+896
+34% +$163K 0.3% 59
2023
Q4
$433K Sell
2,648
-1,102
-29% -$167K 0.46% 41
2023
Q3
$526K Sell
3,750
-461
-11% -$65.6K 0.29% 63
2023
Q2
$563K Buy
4,211
+975
+30% +$126K 0.29% 66
2023
Q1
$424K Sell
3,236
-6,184
-66% -$827K 0.19% 82
2022
Q4
$1.33M Buy
+9,420
New +$1.3M 0.44% 53
2020
Q1
Sell
-103
Closed -$13K 63
2019
Q4
$13K Buy
103
+9
+10% +$1.17K 0.03% 47
2019
Q3
$13K Sell
94
-2,934
-97% -$396K 0.03% 40
2019
Q2
$399K Sell
3,028
-608
-17% -$79.9K 0.23% 81
2019
Q1
$490K Sell
3,636
-263
-7% -$33.5K 0.27% 82
2018
Q4
$424K Buy
3,899
+269
+7% +$32.3K 0.22% 77
2018
Q3
$525K Buy
+3,630
New +$507K 0.19% 87

Other funds holding IBM

Accuvest Global Advisors's IBM Position: Q2 2024 in Review

Accuvest Global Advisors sold out of IBM (IBM) in Q2 2024, closing a stake of 3,544 shares — an estimated $677K sold.

Accuvest Global Advisors first reported a position in IBM in Q3 2018 and held it in 12 quarters. The position peaked at $1.33M in Q4 2022. 2,754 funds tracked by Wall St. Rank hold IBM as of Q2 2024.

  • Accuvest Global Advisors reported no remaining IBM position as of Q2 2024 after selling out during the quarter.
  • Accuvest Global Advisors sold 3,544 IBM shares in Q2 2024, an estimated $677K.
  • Accuvest Global Advisors first reported a position in IBM in Q3 2018 and held it in 12 quarters.
  • Accuvest Global Advisors's IBM position peaked at $1.33M in Q4 2022.
  • 2,754 funds tracked by Wall St. Rank held IBM as of Q2 2024.

Based on Accuvest Global Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.